Similarly, the tumor size and weight were decreased while the percentage and cell number of OT-1+ CD8+ TILs were increased in mice that received ADAM17 KO CD8+ T cells (Fig. 3e and f). This evidence concerns the gene ADAM17 and neoplasm.